24 April 2020 1 Min Read
JSE drops on reports of failed Covid-19 treatment, while rand firms
The Financial Times has reported that the antiviral drug, remdesivir, ‘flopped’ in its first clinical trial
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In